Copyright
©The Author(s) 2021.
World J Diabetes. Oct 15, 2021; 12(10): 1587-1621
Published online Oct 15, 2021. doi: 10.4239/wjd.v12.i10.1587
Published online Oct 15, 2021. doi: 10.4239/wjd.v12.i10.1587
Condition | Glycemic status | Recommendation for metabolic surgery | Evidence category |
Diabetes and BMI ≥ 40 kg/m2 (≥ 37.5 kg/m2 for Asians) | Any | Strong recommendation | A |
Diabetes and BMI 35-39.9 kg/m2 (32.5-37.4 kg/m2 for Asians) | Uncontrolled despite optimal treatment | Moderate recommendation | B |
Diabetes and BMI 30-34.9 kg/m2 (27.5-32.4 kg/m2 for Asians) | Uncontrolled despite optimal treatment | Weak recommendation | C, E |
Diabetes and obesity (BMI – not defined) with comorbidities: Poorly controlled hypertension; Non-alcoholic fatty liver disease; Obstructive sleep apnea; Obesity hypoventilation syndrome; Osteoarthritis of the knee or hip; Urinary stress incontinence; Polycystic ovary syndrome; Gastro-esophageal reflux disease; Idiopathic intracranial hypertension; Severe venous stasis disease; Obesity-related limited mobility; Obesity-related poor quality of life | Any | Weak recommendation | E |
- Citation: Bhattacharya S, Kalra S, Kapoor N, Singla R, Dutta D, Aggarwal S, Khandelwal D, Surana V, Dhingra A, Kantroo V, Chittawar S, Deka N, Bindal V, Dutta P. Expert opinion on the preoperative medical optimization of adults with diabetes undergoing metabolic surgery. World J Diabetes 2021; 12(10): 1587-1621
- URL: https://www.wjgnet.com/1948-9358/full/v12/i10/1587.htm
- DOI: https://dx.doi.org/10.4239/wjd.v12.i10.1587